Author:
Hu Wei,Zhang Peng,Gu Jun,Yu Qiang,Zhang Dadong
Funder
Shanghai Medical Key Specialty Construction Projects
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Biochemistry (medical),Cell Biology,Clinical Biochemistry,Pharmaceutical Science,Pharmacology
Reference41 articles.
1. Xiong J, Xue FS, Yuan YJ, Wang Q, Liao X, Wang WL (2010) Cholinergic anti-inflammatory pathway: a possible approach to protect against myocardial ischemia reperfusion injury. Chin Med J (Engl) 123:2720–2726
2. Hill JH, Ward PA (1971) The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J Exp Med 133:885–900
3. Pinckard RN, Olson MS, Giclas PC, Terry R, Boyer JT, O’Rourke RA (1975) Consumption of classical complement components by heart subcellular membranes in vitro and in patients after acute myocardial infarction. J Clin Invest 56:740–750
4. Rossen RD, Michael LH, Hawkins HK, Youker K, Dreyer WJ, Baughn RE et al (1994) Cardiolipin-protein complexes and initiation of complement activation after coronary artery occlusion. Circ Res 75:546–555
5. Vakeva AP, Agah A, Rollins SA, Matis LA, Li L, Stahl GL (1998) Myocardial infarction and apoptosis after myocardial ischemia and reperfusion: role of the terminal complement components and inhibition by anti-C5 therapy. Circulation 97:2259–2267
Cited by
22 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献